Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
批准号:
8007006
负责人:
Li-Na Wei
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-07 至 2010-12-31
关键词:
AddressAdipocytesAffectAnimal ModelArginineBiologicalBiological ProcessCell Differentiation processCellsChromatinChromatin Remodeling FactorClinicalComplexDefectDiseaseEP300 geneEmbryoEmbryonal CarcinomaEndocrineEventFibroblastsFigs - dietaryGene ConversionGene ExpressionGene TargetingGenesGenetic TranscriptionGoalsHealthHistone DeacetylaseHistonesHomeostasisHormonalHormone ReceptorHormonesHumanKineticsKnock-outKnowledgeLeftLigandsMaintenanceMediatingMediator of activation proteinMetabolic DiseasesMethylationModelingModificationMolecularMolecular Mechanisms of ActionMusMutateNRIP1 geneNuclear ReceptorsNucleic Acid Regulatory SequencesNucleosomesNutrientNutritionalPCAF genePPARBP genePhasePlayPost-Translational Protein ProcessingProgress ReportsPropertyRNA Polymerase IIRXRRecruitment ActivityRegulationRepressionRetinoic Acid BindingRetinoic Acid ReceptorRoleSignal PathwaySignal TransductionSmall Interfering RNASupplementationSystemTestingThyroid HormonesTransferaseTretinoinVitamin Aadipocyte differentiationcell typecellular retinoic acid binding protein Ichromatin remodelinggenetically modified cellshormone response elementhuman NRIP1 proteininsightmouse modelmutantnovelprogramspublic health relevancereceptortranscription factor
中文摘要
描述(由申请人提供):视黄酸(RA),维生素A的生物活性形式,是多种生物过程所必需的。RA与核受体、视黄酸受体(RAR)和类视黄酸受体X (RXR)结合,通过触发共调节因子的募集来调节靶基因的表达,这些共调节因子主要通过染色质重塑和修饰作用于靶基因的调控区域。核受体相互作用蛋白1 (NRIP1,最初称为RIP140)是一种配体依赖的共抑制因子,即它以激素依赖的方式抑制激素诱导靶基因表达。该项目的长期目标是了解维生素A信号的稳态控制机制。该提案的重点是由RIP140和与激素受体形成复合物的共激活因子(如RIP140- rar /RXR复合物和共激活因子- rar /RXR复合物)精心策划的染色质重塑事件,以及几种新发现的翻译后修饰在受体/共调节剂活性调节中的生物学意义。将解决两个问题:1)RIP140如何在激素诱导的染色质重塑中起作用?2)蛋白修饰如何调控RIP140的生物活性?野生型和转基因细胞,包括rip140敲除(RIP-/-)和trap220敲除(TRAP-/-)细胞,以及P19细胞中siRNA介导的基因敲除将被用作主要的实验系统。含有激素反应元件(HREs)的染色质片段将成为检查的目标,以解决生理相关背景下的机制细节。这些研究将通过特定转录因子复合物的协调形成,为激素(维生素A和甲状腺激素)的串扰提供机制见解。这些研究还将揭示对细胞分化程序至关重要的潜在新信号和细胞因子,其中维生素A和其他内分泌因子起着至关重要的作用。从这些研究中获得的知识也可用于了解受激素和营养因素影响或涉及激素和营养因素的临床疾病,如代谢性疾病,这些研究还将描述营养素,如维生素A,在维持人类健康方面的作用。公共卫生相关性:视黄酸(RA)是维生素A的生物活性形式,对多种生物过程至关重要。RA的功能是通过核受体相互作用蛋白1 (NRIP1,最初称为RIP140)的染色质重塑调节靶基因的表达。该项目的长期目标是了解维生素A信号的稳态控制机制。目前的建议侧重于从机制角度研究NRIP1的功能作用。从这些研究中获得的知识也可用于了解受激素和营养因素影响或涉及激素和营养因素的临床疾病,例如代谢性疾病。这些研究还将阐明维生素A等营养素在维持人体健康方面的作用。
英文摘要
DESCRIPTION (provided by applicant): Retinoic acid (RA), the biologically active form of Vitamin A, is essential for a variety of biological processes. RA binds to nuclear receptors, retinoic acid receptor (RAR) and retinoid receptor X (RXR), to regulate target gene expression by triggering recruitment of coregulators that act, primarily, through chromatin remodeling and modification on the regulatory regions of target genes. Nuclear Receptor Interacting Protein 1 (NRIP1, originally known as RIP140) is a ligand-dependent co-repressor, i.e. it represses hormonal induction of target gene expression in a hormone-dependent manner. The long-term goal of this project is to understand the mechanisms underlying homeostatic control of vitamin A signaling. The proposal focuses on chromatin remodeling events orchestrated by RIP140 and coactivators that form complexes with hormone receptors, such as RIP140-RAR/RXR complex and coactivator-RAR/RXR complexes, as well as the biological significance of several newly identified post-translational modifications in the modulation of receptor/coregulator activities. Two questions will be addressed: 1) how does RIP140 function in hormone-induced chromatin remodeling? 2) How does protein modification regulate the biological activity of RIP140? Wild type and genetically modified cells, including RIP140-knockout (RIP-/-) and TRAP220-knockout (TRAP-/-) cells, as well siRNA mediated gene knockdown in P19 cells will be used as the principal experimental systems. Chromatin segments containing hormone response elements (HREs) will be the targets of examination to address mechanistic details in a physiologically relevant context. These studies will provide mechanistic insights into crosstalk of hormones (vitamin A and thyroid hormones) via coordinated formation of specific transcription factor complexes. These studies will also uncover potentially novel signals and cellular factors that are critical to cell differentiation program where vitamin A and other endocrine factors play vital roles. Knowledge gained from these studies could also be applied to understand clinical diseases that are affected by, or involve, hormonal and nutritional factors, such as metabolic diseases, the studies will also delineate the role of nutrients, such as vitamin A, in the maintenance of human health. PUBLIC HEALTH RELEVANCE: Retinoic acid (RA), the biologically active form of Vitamin A, is essential for a variety of biological processes. RA functions by regulating target gene expression through chromatin remodeling that involves Nuclear Receptor Interacting Protein 1 (NRIP1, originally known as RIP140). The long-term goal of this project is to understand the mechanisms underlying homeostatic control of vitamin A signaling. The current proposal focuses on the functional role of NRIP1 from a mechanistic stand point. Knowledge gained from these studies could also be applied to understand clinical diseases that are affected by, or involve, hormonal and nutritional factors, such as metabolic diseases. The studies will also delineate the role of nutrients, such as vitamin A, in the maintenance of human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB SRC on
-
批准号:8719401
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2014
-
负责人:Li-Na Wei
-
依托单位:
TR2 nuclear receptor in vitamin A signaling
-
批准号:8010070
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2010
-
负责人:Li-Na Wei
-
依托单位:
Molecular Mechanisms of Ontogenesis of K-Opioid Receptors
-
批准号:7612853
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2008
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:7802336
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:7599011
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Mechanisms of Ontogenesis of Kappa Opioid Receptors
-
批准号:7513843
-
项目类别:
-
资助金额:$11.36万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:7190873
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:7409730
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:8040951
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the mouse kappa opioid receptor gene
-
批准号:6864823
-
项目类别:
-
资助金额:$12.36万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
NRIP1 in vitamin A signaling pathways
-
批准号:6620340
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:8913322
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:7591104
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
NRIP1 in vitamin A signaling pathways
-
批准号:6874306
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
NRIP1 in vitamin A signaling pathways
-
批准号:6415785
-
项目类别:
-
资助金额:$28.77万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:7787456
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:7452085
-
项目类别:
-
资助金额:$31.59万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of the mouse kappa opioid receptor gene
-
批准号:6621101
-
项目类别:
-
资助金额:$10.31万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:8867875
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:9892993
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: